These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10094198)

  • 1. Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion.
    Benedict CA; Tun RY; Rubinstein DB; Guillaume T; Cannon PM; Anderson WF
    Hum Gene Ther; 1999 Mar; 10(4):545-57. PubMed ID: 10094198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-specific targeting mediated by the coexpression of a targeted murine leukemia virus envelope protein and a binding-defective influenza hemagglutinin protein.
    Lin AH; Kasahara N; Wu W; Stripecke R; Empig CL; Anderson WF; Cannon PM
    Hum Gene Ther; 2001 Mar; 12(4):323-32. PubMed ID: 11242525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An essential role for the His-8 residue of the SDF-1alpha-chimeric, tropism-redirected Env protein of the Moloney murine leukemia virus in regulating postbinding fusion events.
    Katane M; Fujita R; Takao E; Kubo Y; Aoki Y; Amanuma H
    J Gene Med; 2004 Mar; 6(3):260-7. PubMed ID: 15026987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
    Schnierle BS; Moritz D; Jeschke M; Groner B
    Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated targeting of replication-competent retroviral vectors.
    Tai CK; Logg CR; Park JM; Anderson WF; Press MF; Kasahara N
    Hum Gene Ther; 2003 May; 14(8):789-802. PubMed ID: 12804141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient human immunodeficiency virus-based vector transduction of unstimulated human mobilized peripheral blood CD34+ cells in the SCID-hu Thy/Liv model of human T cell lymphopoiesis.
    Douglas JL; Lin WY; Panis ML; Veres G
    Hum Gene Ther; 2001 Mar; 12(4):401-13. PubMed ID: 11242532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular engineering of matrix-targeted retroviral vectors incorporating a surveillance function inherent in von Willebrand factor.
    Hall FL; Liu L; Zhu NL; Stapfer M; Anderson WF; Beart RW; Gordon EM
    Hum Gene Ther; 2000 May; 11(7):983-93. PubMed ID: 10811227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells.
    Pizzato M; Blair ED; Fling M; Kopf J; Tomassetti A; Weiss RA; Takeuchi Y
    Gene Ther; 2001 Jul; 8(14):1088-96. PubMed ID: 11526456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of the N termini of murine leukemia virus envelope proteins.
    Lu CW; Roth MJ
    J Virol; 2001 May; 75(9):4357-66. PubMed ID: 11287584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral display of functional binding domains fused to the amino terminus of influenza hemagglutinin.
    Hatziioannou T; Delahaye E; Martin F; Russell SJ; Cosset FL
    Hum Gene Ther; 1999 Jun; 10(9):1533-44. PubMed ID: 10395378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry.
    Viejo-Borbolla A; Pizzato M; Blair ED; Schulz TF
    Virus Res; 2005 Mar; 108(1-2):45-55. PubMed ID: 15681054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors.
    Christodoulopoulos I; Cannon PM
    J Virol; 2001 May; 75(9):4129-38. PubMed ID: 11287562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.
    Höhne M; Thaler S; Dudda JC; Groner B; Schnierle BS
    Virology; 1999 Aug; 261(1):70-8. PubMed ID: 10441556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
    Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
    Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of chimeric murine leukemia virus env beta-turn polyproline spacers in receptor cooperation.
    Valsesia-Wittmann S
    J Virol; 2001 Sep; 75(18):8478-86. PubMed ID: 11507193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the ligand sequence modifications on the retargeted transduction by the retroviral vector having a ligand-chimeric Env protein.
    Miyakawa K; Fujita R; Katane M; Kubo Y; Amanuma H
    J Gen Virol; 2008 Dec; 89(Pt 12):3137-3143. PubMed ID: 19008403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting strategy for gene delivery to carcinoembryonic antigen-producing cancer cells by retrovirus displaying a single-chain variable fragment antibody.
    Konishi H; Ochiya T; Chester KA; Begent RH; Muto T; Sugimura T; Terada M
    Hum Gene Ther; 1998 Jan; 9(2):235-48. PubMed ID: 9472783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins.
    Chu TH; Martinez I; Sheay WC; Dornburg R
    Gene Ther; 1994 Sep; 1(5):292-9. PubMed ID: 7584094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementation of a binding-defective retrovirus by a host cell receptor mutant.
    Qian Z; Wang H; Empig C; Anderson WF; Albritton LM
    J Virol; 2004 Jun; 78(11):5766-72. PubMed ID: 15140974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G100R mutation within 4070A murine leukemia virus Env increases virus receptor binding, kinetics of entry, and viral transduction efficiency.
    Lu CW; O'Reilly L; Roth MJ
    J Virol; 2003 Jan; 77(1):739-43. PubMed ID: 12477879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.